1. Home
  2. EEIQ vs REVB Comparison

EEIQ vs REVB Comparison

Compare EEIQ & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$0.18

Market Cap

4.3M

Sector

Real Estate

ML Signal

HOLD

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$1.47

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEIQ
REVB
Founded
2017
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
5.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
EEIQ
REVB
Price
$0.18
$1.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
131.6K
1.9M
Earning Date
01-28-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,939,989.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.64
N/A
52 Week Low
$0.15
$1.41
52 Week High
$1.74
$54.48

Technical Indicators

Market Signals
Indicator
EEIQ
REVB
Relative Strength Index (RSI) 30.02 54.67
Support Level $0.15 $1.43
Resistance Level $0.23 $1.63
Average True Range (ATR) 0.03 0.20
MACD -0.00 -0.02
Stochastic Oscillator 20.11 54.05

Price Performance

Historical Comparison
EEIQ
REVB

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: